Article
Genomic correlates of clinical CAR-T cell activity
2025-10-10
Abstract excerpt
<h4>ABSTRACT</h4> Chimeric antigen receptor (CAR)-T cell therapies demonstrate potent anti-tumor efficacy in hematologic malignancies, yet clinical outcomes remain unpredictable due to the bespoke nature of the treatment, which is manufactured from each patient’s own T-cells. While germline variants are known to influence response to immune checkpoint inhibitors 1, 2 , their role in CAR-T cell therapy is unknown....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5d4ae689-404d-5b1a-ba58-8bd8d6d82cd9
- DOI
- 10.1101/2025.10.08.25337584
